Chronic obstructive pulmonary disease (COPD) results from airway inflammation involving multiple inflammatory mediators and tissue damage. It has also been suggested that elevated IgE play a role in chronic airway obstruction [1] . The association of IL-1β gene with COPD has been studied in recent times and its polymorphisms at the position -511 have been found to be associated with susceptibility to COPD [2] .
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Persistent smoking-induced inflammation plays an important role in the pathogenesis of COPD by increasing macrophage and T lymphocyte in bronchial wall and influx of neutrophils into the airway lumen; however only a fraction of smokers end up in developing COPD [3] .
IgE immune complexes stimulate FcεRII and mediate expression and release of IL-1β by mononuclear cells [4] . Serum IgE levels are often increased in smokers [5] which may induce IL-1β expression in monocytes. The present study was undertaken to investigate the association and potential activity of serum IL-1β and IgE levels in COPD.
The test group consisted of 30 current smokers (age: 48 to 66 yrs) with moderate to severe COPD. All the patients had a history of smoking an average of 19 pack/year (10-40 pack/ year) for 30 years (10-40 years). The diagnosis of COPD was made using the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) standard [6] . Thirty healthy and non-smoker volunteers constituted the control group. Spirometry, routine blood investigations, chest X-rays, stool test for parasites and skin prick test (SPT) with 10 common allergen extracts (Cockroach male, Cockroach female, Housefly, Moth, Butterfly, House dust, House Dust Mite, Aspergillus, Cynodon, Chenopodium) were performed on all patients. The Student's t or MannWhitney U test was used to evaluate the differences in continuous variables. Pearson's rank correlation was applied to assess the association between various pulmonary function tests and immunological parameters.
In the control group, the IL-1β level was 2.11±0.16 pg/ml (range: 0.39-2.97 pg/ml), which was significantly lower than COPD patients (3.14±0.07, range: 2.8-4.59 pg/ml, p< 0.05). The mean serum IgE levels were 41.9±3.58 IU/ml (range: 28-65 IU/ml) in controls and 112.3±4.22 IU/ml (range: 78-169 IU/ml) in COPD patients (p<0.001). Stool test was found to be negative for parasitic infestation and eosinophil count was in the normal range in both the groups.
The FEV 1 percent of predicted in controls was 80 to 100% (mean 88.8% ±0.95) while in COPD patients it ranged between 17 to 66 % (39.8% ±2.61). FVC percent of predicted ranged from 85 to 103% (90.5% ±1.18) in controls and 51 to 78% (69.5±1.53) in COPD patients. Mean FEV 1 /FVC ratio in controls was 0.84±.01 and 0.43±0.01 in COPD patients. Both FEV 1 and FEV 1 /FVC were significantly lower in cases than the control group (p<0.001). In smokers, the risk for developing COPD is dose related [6] . Smoking results in a non-specific increase in IgE as a result of interference with IgE regulatory mechanisms. Mechanism for IgE production in airways of smokers might be due to tobacco or due to induction of allergenic altered proteins in the airway as seen in isocyanate sensitivity [5] or due to increased B cells in COPD [7] . In the present study, IgE levels were significantly elevated in COPD patients in spite of their non atopic status as confirmed by negative skin prick tests. Renkema et al also demonstrated a higher initial serum IgE level in non atopic COPD patients [8] .
The present study demonstrated significantly high levels of IL-1β in serum of the COPD patients as compared to the healthy controls. A few studied previously undertaken have also reported a rise in IL-1β in COPD cases [9] . It can thus be speculated that in COPD, IL-1β expression may be induced in monocytes due to increased IgE levels, which may lead to their increased release in blood, although we could not observe any correlation between both IL-1β and IgE due to the limited sample size.
FEV 1 and FEV 1 /FVC ratio aid to identify airflow obstruction where as FVC predicts restrictive pattern of obstruction. In the present study, the subjects who were chronic smokers, suffered from moderate to severe airway obstruction as FEV 1 and FEV 1 /FVC were significantly lower. We observed that IgE correlated inversely with FVC whereas IL-1β correlated inversely with FEV 1 , though neither of them depicted any correlation with the ratio FEV 1 /FVC. Several studies show a significant excess decline in FEV 1 in smokers over non-smokers, ex-smokers and quitters [10] . Increased levels of circulating cytokines and acute phase reactants have been seen in the peripheral circulation of patients suffering from COPD, especially during exacerbations. Sapey et al have proved that IL-1β plays critical role in COPD where it was found to correlate significantly with FEV 1 suggesting its role in clinical aspects of disease severity [9] .
Modulation of various inflammatory mediators may help in combating the clinical outcome of COPD and may have therapeutic implications whereas determination of serum IL-1β levels may help in differentiating COPD from other respiratory disorders such as asthma [11] . The present study has a few limitations. It was cross-sectional, so its ability to infer causality is limited. Population based studies are required to validate the findings. Levels of IgE and IL-1β in broncho-alveolar lavage would give a better picture of cytokine milieu in COPD instead of serum levels. Despite these limitations, the findings of this study were significant and may provide an insight into the role of IgE and IL-1β in severity of COPD. 
